Clinical Trial Update: Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on the treatment of chronic hand eczema with oral roflumilast (HERO).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Jacob Pontoppidan Thyssen | Conditions: Chronic Hand Eczema | Phase 4 | Status: UNKNOWN